Clinical Characteristics and Outcome of Patients With COPD With Pneumonia
- Conditions
- PneumoniaChronic Obstructive Pulmonary Disease
- Interventions
- Other: No inervention
- Registration Number
- NCT04966026
- Lead Sponsor
- Peking University Third Hospital
- Brief Summary
To identify the clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing clinical transition.
- Detailed Description
To identify the clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing clinical transition.Compared to other chronic airway diseases, COPD patients can often have CAP in combination, but there is a lack of comparative studies between COPD patients with CAP and non-COPD patients with CAP.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 143
- CAP meets the diagnostic criteria published in 2016 Chinese CAP diagnosis and treatment guidelines; CPOPD and AECOPD meet the diagnostic criteria published in Chinese 2013 COPD diagnosis and treatment guidelines;
- Age ≧ 40years.
- age <40years;
- pregnancy;
- positive for human immunodeficiency virus (HIV) antibodies;
- suspected or confirmed tuberculosis or fungal infection of the lung.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description COPD combined with CAP inpatients No inervention (1) CAP meets the diagnostic criteria published in our 2016 CAP diagnosis and treatment guidelines; CPOPD and AECOPD meet the diagnostic criteria published in our 2013 COPD diagnosis and treatment guidelines; (2) age ≧ 18 years. Exclusion criteria: (1) age \<18 years; (2) pregnancy; (3) positive human immunodeficiency virus (HIV) antibody; (4) suspected or confirmed tuberculosis or fungal infection of the lung.
- Primary Outcome Measures
Name Time Method mortality rate Day 28 from hospitalization mortality rate
- Secondary Outcome Measures
Name Time Method number of days in ICU through study completion, an average of 1 year number of days in ICU
hospital fees through study completion, an average of 1 year hospital fees.
cause of using antimicrobial drugs through study completion, an average of 1 year Days of using antimicrobial drugs during hospitalization
Number of days in hospital through study completion, an average of 1 year Number of days in hospital
number of days on mechanical ventilation through study completion, an average of 1 year number of days on mechanical ventilation
Trial Locations
- Locations (1)
Peking University Third Hospital
🇨🇳Beijing, Beijing, China